By Aaron Hochman-Zimmerman
New York, Sept. 26 - Elbit Medical Imaging Ltd. priced two tranches (A+, Maalot) totaling NIS 403 million, according to a press release.
The amount of the Regulation S deal was raised from NIS 350 million.
The series E bonds will carry an interest rate of 6.3%, 0.2% lower than the maximum rate offered, and the series F bonds will carry an interest rate of 5.7%, also 0.2% lower than the maximum rate offered.
The Tel Aviv, Israel-based firm primarily deals in the development of commercial centers, hotel and property management in central and eastern Europe.
| Issuer: | Elbit Medical Imaging Ltd.
|
| Amount: | NIS 403 million
|
| Issue: | Series E tranche, Series F tranche
|
| Coupon: | Series E 6.3%, Series F 5.7% (Israel CPI-linked)
|
| Pricing date: | Sept. 26
|
| Settlement date: | Sept. 30
|
| Distribution: | Regulation S
|
| Rating: | (A+, Maalot)
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
